UBX-303061 in Subjects With Relapsed/Refractory B-Cell Malignancies
for Relapsed/Refractory B-cell Malignancies
3 locations incl. Ann Arbor
Sponsor: Ubix Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT06590961·Phase 1·Recruiting·Listed Sep 2024
Gabrail Cancer Center
Clinical research site in Canton, Oklahoma
Part of Gabrail Cancer Center
As of July 2026, 1 paid clinical trial is recruiting at Gabrail Cancer Center in Canton, Oklahoma. Active studies at this site focus on Relapsed/Refractory B-cell Malignancies alongside other indications. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at Gabrail Cancer Center (1)
Explore more
Paid clinical trials in Canton, OK · Oklahoma clinical trials